Chemotherapy Induced Neutropenia Completed Phase 2 Trials for Pegfilgrastim (DB00019)

Also known as: Neutropenia post-chemotherapy / Chemotherapy-Induced Neutropenia / Chemotherapy Associated Neutropenia / Chemotherapy-induced neutropenia (disorder) / Neutropenia, unspecified / Neutropenia / Neutropenia (disorder) [Ambiguous] / Neutropenic disorder (disorder) / (Agranulocytosis) or (Kostmann's syndrome) or (neutropenia) / Neutropenias

IndicationStatusPhase
DBCOND0051348 (Chemotherapy Induced Neutropenia)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04345900Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 2Treatment
NCT04227990Plinabulin iv Solution in Prevention of TAC Induced NeutropeniaSupportive Care